The Knowledge Community Insider
Featuring Monthly News from Wexford and our Knowledge Communities |
|
| Wexford cuts ribbon on newest project in Phoenix, 850 PBC |
|
| On March 30th, Wexford Science & Technology, along with Arizona State University, and the City of Phoenix, officially opened 850 PBC located on the Phoenix Biomedical Campus in downtown Phoenix. |
|
| Marco A. Chacon, PhD, joins Wexford as Chief Scientific Officer |
|
|
Marco A. Chacon, PhD. has joined Wexford Science & Technology, LLC, as the company’s first Chief Scientific Officer. As a successful serial entrepreneur, Chacon brings a depth of experience that will allow him to help life science companies take full advantage of connections to universities and entrepreneurs that are at the core of Wexford’s Knowledge Communities.
“We are delighted Marco has joined our team and will be bringing his unique talents and expertise to our company” said Jim Berens, founder and CEO of Wexford. “Marco has had great success starting and growing companies at the University of Maryland BioPark and he will be a great asset to our executive management team,” Berens continued.
Chacon may be best known as the Founder and former Chairman of Paragon Bioservices, Inc., a contract development and GMP manufacturing organization (CDMO) that specialized in process development and GMP manufacturing of viral vectors for gene therapy. In May of 2019, Paragon was acquired by Catalent Pharma Solutions—a global CMO—for $1.2 Billion. |
Most recently, Chacon was the Founder and President of IRAZÚ Bio-Holdings LLC., a company dedicated to early-stage technology development, while bridging the uncertain divide between academic research and drug development.
“It is with great joy that I start a new chapter in my long career as CSO of Wexford Science & Technology—a visionary organization dedicated to the creation of Knowledge Communities. It is in this capacity that I will continue to engage in one of my life’s passions…to support translational medicine and early-stage technology development while promoting entrepreneurship and the convergence of Academic Research and Industry,” said Marco Chacon.
Dr. Chacon’s academic interests include energy metabolism, oxygen homeostasis and the regenerative potential of tissues and organs. |
|
ASU cuts ribbon on newest biomedical facility in downtown Phoenix
ASU News | March 30, 2021
The din of construction on the northeast corner of Garfield and Fifth streets in downtown Phoenix will soon give way to a flurry of activity as the researchers and entrepreneurs who will inhabit half of the new 225,000-square-foot building that now stands there move in to embark on journeys of discovery and advancement that promise to enhance the health and vibrancy of the surrounding community. |
|
|
Duke Starts Sequencing COVID Genes, Finds Two Known Variants
Duke News | March 4, 2021
As a next step in Duke University’s exhaustive, campus-wide testing program during the COVID pandemic, the university is employing a genome sequencing core facility in downtown Durham to identify the specific strains of the SARS-CoV-2 virus that have been found on the campus and in the Duke Health system. |
|
|
| Fore Biotherapeutics Opens U.S. Headquarters in Philadelphia’s Biotech Hub
Business Wire | May 10, 2021
Fore Biotherapeutics (formerly NovellusDx), a precision oncology company focused on providing people with rare cancer mutations rapid access to the right medicines, today announced that it is opening its global headquarters in Philadelphia.
|
|
|
| ASU, Phoenix hope to lure researchers, entrepreneurs with new downtown innovation center
AZ Central | May 5, 2021
The 227,000 square foot building will house a startup incubator, ASU programs and private science and technology companies on its seven floors. The researchers and companies planning to move into the building cover a wide range of scientific expertise, such as cancer research and nutrition research.
|
|
|
| Newest Phoenix Biomedical Campus building is the ‘heart, nexus’ between communities
Downtown Devil | April 12, 2021
In partnership with Wexford Science + Technology and the City of Phoenix, Arizona State University opened its newest building (PBC1) on the Phoenix Biomedical Campus to promote entrepreneurship and economic development.
|
|
|
| A Unique Talent Pool is Propelling Philly to become a Top Biotech Cluster
BioBuzz | March 24, 2021
As some are now calling it, the greater Philadelphia region, or ‘Cellicon Valley’ is garnering a lot of attention these days as a rapidly emerging Biopharma cluster…
|
|
|
|
|
|
